Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

TNF-alpha enhances Toxoplasma gondii cyst formation in human fibroblasts through the sphingomyelinase pathway.

Ricard J, Pelloux H, Pathak S, Pipy B, Ambroise-Thomas P.

Cell Signal. 1996 Sep;8(6):439-42.

PMID:
8958446
2.

Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609.

Pörn-Ares MI, Chow SC, Slotte JP, Orrenius S.

Exp Cell Res. 1997 Aug 25;235(1):48-54.

PMID:
9281351
3.

Induction of Toxoplasma gondii cystogenesis and multiplication arrest by treatments with a phosphatidylcholine-specific phospholipase C inhibitor.

Ricard J, Pelloux H, Gross U, Meunier A, Ambroise-Thomas P.

J Parasitol. 1999 Jun;85(3):583-5.

PMID:
10386462
7.

Tumor necrosis factor-alpha, sphingomyelinase, and ceramide inhibit store-operated calcium entry in thyroid FRTL-5 cells.

Törnquist K, Malm AM, Pasternack M, Kronqvist R, Björklund S, Tuominen R, Slotte JP.

J Biol Chem. 1999 Apr 2;274(14):9370-7.

8.

Inhibition of protein kinase C translocation from cytosol to membrane by chelerythrine.

Chao MD, Chen IS, Cheng JT.

Planta Med. 1998 Oct;64(7):662-3.

PMID:
9810275
9.

Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts.

Jordan NJ, Watson ML, Yoshimura T, Westwick J.

Br J Pharmacol. 1996 Mar;117(6):1245-53.

10.

Toxoplasma gondii: role of the phosphatidylcholine-specific phospholipase C during cell invasion and intracellular development.

Ricard J, Pelloux H, Favier AL, Gross U, Brambilla E, Ambroise-Thomas P.

Exp Parasitol. 1999 Mar;91(3):231-7.

PMID:
10072325
11.

TNF-stimulated arginine transport by human vascular endothelium requires activation of protein kinase C.

Pan M, Wasa M, Lind DS, Gertler J, Abbott W, Souba WW.

Ann Surg. 1995 May;221(5):590-600; discussion 600-1.

12.

Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.

Johns LD, Sarr T, Ranges GE.

J Immunol. 1994 Jun 15;152(12):5877-82.

PMID:
8207213
13.

Tumor necrosis factor-alpha induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways.

Sortino MA, Condorelli F, Vancheri C, Canonico PL.

Endocrinology. 1999 Oct;140(10):4841-9.

PMID:
10499544
14.

Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase.

Chmura SJ, Nodzenski E, Weichselbaum RR, Quintans J.

Cancer Res. 1996 Jun 15;56(12):2711-4.

15.

Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.

Meng A, Luberto C, Meier P, Bai A, Yang X, Hannun YA, Zhou D.

Exp Cell Res. 2004 Jan 15;292(2):385-92.

PMID:
14697345
16.

Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells.

Raines MA, Kolesnick RN, Golde DW.

J Biol Chem. 1993 Jul 15;268(20):14572-5.

17.

Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.

Mori K, Stone S, Braverman LE, DeVito WJ.

Endocrinology. 1996 Nov;137(11):4994-9.

PMID:
8895373
20.

Supplemental Content

Support Center